Overview

Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the efficacy of denosumab, a new drug, in the treatment of osteoporosis in patients using bisphosphonates.
Phase:
Phase 4
Details
Lead Sponsor:
Tuen Mun Hospital
Treatments:
Denosumab
Diphosphonates
Glucocorticoids